간세포성장인자와 신장질환
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박준성 | - |
dc.contributor.author | 김근호 | - |
dc.date.accessioned | 2022-07-16T22:31:40Z | - |
dc.date.available | 2022-07-16T22:31:40Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2211-9132 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169380 | - |
dc.description.abstract | Hepatocyte growth factor (HGF), also known as scatter factor, was identified during the experimental attempts to explore a phantom factor acting as a trigger for liver regeneration after partial hepatecotmy. HGF is synthesized and secreted as a single-chain inert precursor by cells of mesodermal origin, and extracellularly processed to the two-chain functional heterodimer by proteolytic cleavage at a specific site. The binding of HGF to the c-MET, the HGF receptor, induces activation of tyrosine kinase and autophosphorylation of tyrosine residues. c-MET activation propagates an intricate system of signaling pathways that controls a range of cellular processes as diverse as cell proliferation, differentiation, transformation and apoptosis. In the aspect of kidney, the HGF/c-MET signaling pathway plays important roles in renal development and in the maintenance of normal adult kidney structure and function. In various injury and disease models, HGF has been reported to promote cell survival, tissue regeneration, and fibrosis suppression. Neutralization of HGF by the antibody may accelerate renal failure or fibrosis while HGF administration may lead to remarkable amelioration. Thus, HGF is not only the endogenous safeguard protecting normal tissues against the fibrotic process after injury, but also a therapeutic option to prevent organ failure. If insufficient production of HGF is causative for renal fibrosis, administration of recombinant human HGF protein or HGF gene therapy may improve renal fibrosis and dysfunction. HGF gene therapy requires appropriate delivery systems, and biodegradable polyester amine based on glycerol dimethacrylate and polyethylenimine is being tested for the HGF gene carrier in experimental models. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한신장학회 | - |
dc.title | 간세포성장인자와 신장질환 | - |
dc.title.alternative | Hepatocyte Growth Factor and Kidney Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김근호 | - |
dc.identifier.bibliographicCitation | Kidney Research and Clinical Practice, v.30, no.4, pp.359 - 367 | - |
dc.relation.isPartOf | Kidney Research and Clinical Practice | - |
dc.citation.title | Kidney Research and Clinical Practice | - |
dc.citation.volume | 30 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 359 | - |
dc.citation.endPage | 367 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001573173 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Fibrosis | - |
dc.subject.keywordAuthor | Gene therapy | - |
dc.subject.keywordAuthor | Hepatocyte growth factor | - |
dc.subject.keywordAuthor | Gene transfer techniques | - |
dc.subject.keywordAuthor | Kidney failure | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.